Determining the Appropriateness and Acceptability of a Reduced Postradiotherapy Surveillance Practice in Breast Cancer Patients: Results of a Longitudinal Observational Study

Greta-Henrike Holtgrave,Anne Caroline Knöchelmann,Hans Christiansen,Frank Bruns

DOI: https://doi.org/10.1155/2024/7672183

IF: 2.1

2024-02-22

European Journal of Cancer Care

Abstract:Postradiotherapy surveillance, which aims to detect and treat radiation injury, is important from the patient’s perspective, but also from the radiation oncologist’s perspective. Unfortunately, patient nonattendance increases over the course of five years. The aim of the study was to investigate the appropriateness and acceptability of reduced versus usual (conventional) postradiotherapy surveillance in breast cancer patients. A total of 192 consecutive patients with curatively irradiated breast cancer from two selected treatment years were included in our study, of whom 65 were offered six (after three months, 12 months, 24 months, 36 months, 48 months, and 60 months) and 127 were offered four follow-up appointments (after three months, 12 months, 36 months, and 60 months). Their patient-, tumour- and treatment-related characteristics were analysed, as well as follow-up events and attendance rates. The reduced four-meeting surveillance practice shows similar results to the traditional six-meeting practice in terms of appropriateness and acceptability, with significantly higher attendance rates at 36 and 60 months ( p = 0.014 and 0.013 , respectively) when the individual moments are compared on a one-to-one basis. The patient-, tumour-, and treatment-related variables examined did not show an effect on the attendance rate. There was also no significant difference between the two cohorts in the detection of follow-up events (such as recurrence) and late radiation effects. In conclusion, this retrospective study provides scientific support for the trend towards a risk-adjusted, reduced surveillance practice in radiation oncology. In particular, four postradiotherapy follow-up visits seem to be appropriate and accepted in breast cancer patients after curative postoperative breast irradiation. This reduced postradiotherapy surveillance practice has the advantage of saving time for the patient and resources for the healthcare system without compromising quality; it could also improve patient participation. We, therefore, recommend it as an appropriate standard for breast cancer patients.

nursing,oncology,health care sciences & services,rehabilitation

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the appropriateness and acceptability in the follow - up practice of breast cancer patients after radiotherapy. Specifically, the study aims to explore whether reducing the number of follow - up visits (i.e., from the traditional six follow - up visits to four follow - up visits) can maintain the same appropriateness and acceptability as the traditional follow - up practice, while increasing the patient's follow - up participation rate and not affecting the detection effect of recurrence, metastasis, second primary tumors or late - stage radiation effects.

### Research Background
Follow - up after radiotherapy is very important for detecting and treating radiation damage, not only from the patient's perspective but also from the perspective of radiation oncologists. However, the patient's follow - up participation rate gradually decreases over time, especially during the five - year follow - up period. Therefore, the research team hopes to improve patient participation by reducing the number of follow - up visits without reducing the quality and effectiveness of follow - up.

### Research Methods
The research team conducted a retrospective longitudinal observational study, including 192 breast cancer patients who had received radical postoperative radiotherapy within two selected treatment years. Among them, 65 patients received six follow - up visits (at 3 months, 12 months, 24 months, 36 months, 48 months and 60 months after radiotherapy respectively), while 127 patients received four follow - up visits (at 3 months, 12 months, 36 months and 60 months after radiotherapy respectively). The study analyzed the patients' baseline characteristics, follow - up events and participation rates.

### Main Findings
1. **Detection of Follow - up Events**: There was no significant difference between the two groups of patients in the detection of follow - up events such as recurrence, metastasis, second primary tumors or death.
2. **Late - stage Radiation Effects**: There was also no significant difference between the two groups of patients in the detection of late - stage radiation effects.
3. **Participation Rate**: At 36 months and 60 months, the participation rate of the group with reduced number of follow - up visits (four follow - up visits) was significantly higher than that of the traditional group (six follow - up visits), which were 63% vs 48% (p = 0.014) and 33% vs 23% (p = 0.013) respectively.

### Conclusions
The study shows that reducing the number of follow - up visits after radiotherapy to four is appropriate and acceptable, which can increase the patient's participation rate without affecting the detection effect of important follow - up events. This practice of reducing the number of follow - up visits can save the patient's time and medical resources without reducing the quality of follow - up. Therefore, the research team recommends four follow - up visits as the standard follow - up practice for breast cancer patients.

### Future Directions
Although this retrospective study provides evidence to support the reduction of the number of follow - up visits, in order to further verify its non - inferiority, prospective studies are needed in the future.